UBD and neoplasm: In immunogenic tumors (e.g., SKCM), UBD upregulation is linked to the C2 (IFN-γ-dominant) immune subtype, characterized by CD8+ T cell infiltration and pro-apoptotic activity, promoting anti-tumor responses.